Health Utility Elicitation: Is There Still a Role for Direct Methods?

By Prosser Lisa A.  

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 83-86

Adis International

Access to resources Recommend Favorite

Individualising Aminoglycoside Dosage Regimens after Therapeutic Drug Monitoring: Simple or Complex Pharmacokinetic Methods?

By Tod M.M.  

Clinical Pharmacokinetics, Vol. 40, Iss. 11, 2001-01 ,pp. : 803-814

Adis International

Access to resources Recommend Favorite

Prediction of Cytochrome P450-Mediated Hepatic Drug Clearance in Neonates, Infants and Children: How Accurate Are Available Scaling Methods?

By Björkman Sven  

Clinical Pharmacokinetics, Vol. 45, Iss. 1, 2006-01 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

By Stout Natasha K.   Knudsen Amy B.   >   McMahon Pamela M.   Gazelle G. Scott  

PharmacoEconomics, Vol. 27, Iss. 7, 2009-07 ,pp. : 533-545

Adis International

Access to resources Recommend Favorite

Practice guidelines of poor quality?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite